Journal of Clinical and Translational Hepatology
Scope & Guideline
Advancing hepatology for better patient outcomes.
Introduction
Aims and Scopes
- Clinical Application of Hepatology Research:
The journal emphasizes studies that translate laboratory findings into clinical applications, particularly focusing on hepatocellular carcinoma, autoimmune liver diseases, and metabolic liver disorders. - Innovative Diagnostic Techniques:
Research on novel diagnostic methods including imaging techniques, biomarkers, and non-invasive assessments of liver diseases is a significant focus. - Therapeutic Advancements:
The journal publishes studies on new therapeutic approaches for liver diseases, including drug development, immunotherapy, and combination treatments. - Epidemiological Studies:
There is a strong emphasis on epidemiological research that explores the prevalence, risk factors, and outcomes of liver diseases in diverse populations. - Pathophysiological Mechanisms:
The journal covers research that elucidates the underlying mechanisms of liver diseases, including metabolic dysfunction, viral infections, and immune responses. - Patient-centered Outcomes:
Research focusing on health-related quality of life, patient-reported outcomes, and the psychosocial impacts of liver diseases is also a core area.
Trending and Emerging
- Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD):
Research focused on MAFLD has surged, reflecting growing recognition of its clinical significance and the need for tailored therapeutic strategies. - Immunotherapy and Personalized Medicine:
There is a rising interest in immunotherapeutic approaches for liver cancer and personalized medicine strategies that consider individual genetic and phenotypic variations. - Gut-Liver Axis Research:
Emerging studies exploring the role of gut microbiota in liver disease pathogenesis and treatment responses are increasingly prominent, indicating a multidisciplinary approach to liver health. - Artificial Intelligence and Machine Learning:
The integration of AI and machine learning in diagnosing and predicting outcomes in liver diseases is gaining traction, showcasing the journal's commitment to innovative research methodologies. - Patient-Centric Research:
There is an increasing focus on patient-reported outcomes and quality of life assessments, reflecting a broader trend towards prioritizing patient experiences in clinical research. - Viral Hepatitis and Novel Therapeutics:
Ongoing research into hepatitis viruses, particularly hepatitis B and C, continues to evolve with the advent of novel therapeutic agents and treatment regimens.
Declining or Waning
- Traditional Pharmacotherapy for Hepatitis:
Research related to traditional antiviral therapies for hepatitis B and C is declining as new, more effective agents and treatment protocols are being developed and adopted. - Invasive Diagnostic Procedures:
There is a noticeable decrease in studies focusing on invasive diagnostic procedures for liver diseases, as non-invasive methods gain preference due to their safety and efficacy. - Longitudinal Studies of Chronic Liver Disease:
Long-term follow-up studies of chronic liver disease are less frequently published, potentially due to a shift towards more immediate clinical outcomes and treatment efficacy studies. - Basic Science without Clinical Relevance:
Research that does not directly link basic science findings to clinical applications is becoming less common, as the journal prioritizes translational research that impacts patient care. - Studies on Rare Liver Diseases:
There is a reduction in the volume of studies focused on rare liver diseases, possibly due to limited patient populations and funding opportunities.
Similar Journals
Egyptian Liver Journal
Innovative findings shaping the future of liver care.The Egyptian Liver Journal, ISSN 2090-6218, is a vital resource for the hepatology community, published by SPRINGEROPEN. Since its establishment in 2012, this journal has served as a platform for disseminating significant findings in liver research, with an emphasis on enhancing understanding and treatment of liver diseases. Recognized with a Q3 ranking in Hepatology for 2023, the Egyptian Liver Journal aims to bridge the gap between research and clinical practice through its commitment to open access, fostering a global exchange of knowledge without barriers since 2019. With a focus on innovative studies, reviews, and clinical guidelines, the journal appeals to a diverse audience of researchers, clinicians, and students dedicated to advancing liver health. Situated in the heart of the United States, this publication addresses the pressing issues within the field and encourages submissions that address the future of liver care and treatment.
JOURNAL OF HEPATOLOGY
Inspiring Progress in Hepatologic KnowledgeJOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.
Annals of Hepatology
Connecting researchers and clinicians in the quest for liver health.Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.
Expert Review of Gastroenterology & Hepatology
Exploring the Frontiers of Digestive HealthExpert Review of Gastroenterology & Hepatology is a premier journal published by Taylor & Francis Ltd that aims to bridge the gap between clinical practice and research in the fields of gastroenterology and hepatology. Established in 2007, this journal has rapidly gained recognition, boasting a Q1 ranking in Gastroenterology and a Q2 ranking in Hepatology for 2023, while achieving impressive Scopus rankings of 31st and 25th respectively in these disciplines, placing it within the top 81st and 70th percentiles. The journal’s objective is to provide a comprehensive platform for the latest developments, innovative treatments, and critical reviews, catering to researchers, healthcare professionals, and students alike. Located in the United Kingdom, the journal does not operate under an open access model but ensures that its content is accessible to a global audience through institutional subscriptions. By consistently publishing high-impact reviews and articles, Expert Review of Gastroenterology & Hepatology solidifies its role as a vital resource in advancing knowledge and clinical practice within these challenging and evolving fields.
Gastroenterologia y Hepatologia
Elevating the standard of care through cutting-edge research.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.
Hepatology International
Fostering collaboration for impactful liver research.Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.
Korean Journal of Gastroenterology
Championing Breakthroughs in GastroenterologyKorean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.
Frontline Gastroenterology
Innovating Insights in Gastrointestinal HealthFrontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.
Journal of Gastrointestinal and Liver Diseases
Pioneering Insights for a Healthier Digestive SystemThe Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.
With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.
International Journal of Hepatology
Bridging research and clinical practice in hepatology.The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.